MedPath

Effect of transarterial infusion therapy using carboplatin for hepatocelluar carcinoma with macroscopic vascular invasio

Not Applicable
Recruiting
Conditions
Hepatocelluar carcinoma
Registration Number
JPRN-UMIN000016041
Lead Sponsor
Fujita Health University School of Medicine Depertment of hepatobiriary and transplant surgery
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1)Case with Extrahepatic metastasis 2)Case with complication as below(excluded chronic hepatitis and chirrosis) (1)Uncontrollable Cardiac dysfunction (2)AMI onset within 6 months (3)Renal failure (4)Active infection(excluded viral hepatitis) (5)Active GI bleeding (6)Active double cancer (7)Hepatic coma and mentalillness 3)Pregnantwoman,nursewoman and possible pregnantwoman 4)Case that are not suitable and not listed above

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Desease free survival
Secondary Outcome Measures
NameTimeMethod
respons rate of transarterial infusion therapy using CAM(carboplatin, adoriamaicin, mitomycin C), Over all survival, safty
© Copyright 2025. All Rights Reserved by MedPath